Rilpivirine Tablet, Film Coated
Product Images NDC 70069-848

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rilpivirine (NDC 70069-848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rilpivirine-structure (8d833cc1 60b6 4e31 Aff3 2958b8f93d1f 01)

Chemical structure of rilpivirine hydrochloride, showing the molecular arrangement of the active ingredient rilpivirine with associated hydrochloride.*

FDA Label Image

Desc (8d833cc1 60b6 4e31 Aff3 2958b8f93d1f 02)

Label for Rilpivirine Tablets 25 mg, film-coated oral tablets, containing 30 tablets per bottle. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ, and made in India. The label includes storage instructions, dosage guidance, and cautionary notes regarding the product and its substitution status. The NDC is 70069-848-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.